avitriptan has been researched along with Migraine Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbhaiya, RH; Duncan, GF; Greene, DS; Larkin, KD; Marathe, PH | 1 |
| Couch, JR; Meloche, JP; Saper, J | 1 |
| Bax, WA; De Vries, P; Heiligers, JP; Maassen vandenBrink, A; Saxena, PR; Wang, W; Yocca, FD | 1 |
| Elkind, A; Goldstein, J; Ryan, RE | 1 |
| Cutler, NR; Ford, N; Fulmor, IE; Jhee, SS; Salazar, DE; Smith, RA; Sramek, JJ | 1 |
| Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR | 1 |
| Dahlöf, CG; Falk, L; Lewis, CP; Risenfors, M | 1 |
| Edvinsson, L; Goadsby, PJ; Knight, YE | 1 |
4 trial(s) available for avitriptan and Migraine Disorders
| Article | Year |
|---|---|
Treatment of migraine with BMS180048: response at 2 hours. North American BMS180048 Study Group.
Topics: Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sulfonamides; Time Factors; Tryptamines | 1996 |
Twenty-four-hour effectiveness of BMS 180048 in the acute treatment of migraine headaches.
Topics: Acute Disease; Double-Blind Method; Humans; Indoles; Migraine Disorders; Salvage Therapy; Serotonin Receptor Agonists; Sulfonamides; Time Factors; Tryptamines | 1997 |
Pharmacokinetics and pharmacodynamics of avitriptan in patients with migraine after oral dosing.
Topics: Administration, Oral; Adolescent; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Tryptamines | 1998 |
Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
Topics: Adult; Chest Pain; Diagnosis, Differential; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Myocardial Ischemia; Neck Pain; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Safety; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Tryptamines; Ultrasonography | 1998 |
4 other study(ies) available for avitriptan and Migraine Disorders
| Article | Year |
|---|---|
Determination of a novel indolylpiperazine anti-migraine agent in rat, monkey, mouse and rabbit plasma by high-performance liquid chromatography with electrochemical detection.
Topics: Animals; Buffers; Chromatography, High Pressure Liquid; Drug Stability; Electrochemistry; Haplorhini; Hydrogen-Ion Concentration; Indoles; Kinetics; Mice; Migraine Disorders; Quaternary Ammonium Compounds; Rabbits; Rats; Sensitivity and Specificity; Sulfonamides; Tryptamines | 1996 |
Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential.
Topics: Animals; Arteriovenous Anastomosis; Blood Pressure; Carotid Arteries; Coronary Vessels; Head; Heart Rate; Hemodynamics; Humans; Indoles; Migraine Disorders; Muscle Contraction; Muscle, Smooth, Vascular; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Swine; Tryptamines; Vasoconstrictor Agents | 1997 |
Coronary side-effect potential of current and prospective antimigraine drugs.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 1998 |
Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Topics: Animals; Calcitonin Gene-Related Peptide; Cats; Cerebral Arteries; Cerebrovascular Circulation; Cranial Sinuses; Electric Stimulation; Indoles; Jugular Veins; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Trigeminal Nerve; Tryptamines | 1999 |